Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

NCT01598025 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Closed due to poor accrual

Conditions

Acute Leukemia
Chronic Leukemia
Myelodysplastic Syndrome
Non-Hodgkins Lymphoma

Interventions

RADIATION: total-body irradiation (TBI)
DRUG: thiotepa
DRUG: fludarabine phosphate
DRUG: melphalan
BIOLOGICAL: anti-thymocyte globulin
PROCEDURE: allogeneic hematopoietic stem cell transplantation
BIOLOGICAL: peripheral blood stem cell transplantation
OTHER: laboratory biomarker analysis

Sponsor

Memorial Sloan Kettering Cancer Center